RECEPTORS FOR IMMUNOGLOBULIN G ON LEUKOCYTES
RECEPTORS FOR IMMUNOGLOBULIN G ON LEUKOCYTES
批准号:
2376777
负责人:
BICE PERUSSIA
金额:
$28.57万
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-04-01 至 1999-02-28
关键词:
B lymphocyte antibody receptor antireceptor antibody biological signal transduction cytokine enzyme activity enzyme linked immunosorbent assay human tissue immune complex immunoglobulin G laboratory mouse leukocyte activation /transformation ligands macrophage molecular cloning monoclonal antibody monocyte natural killer cells phospholipase C phosphoprotein phosphatase phosphorylation protein kinase receptor binding tissue /cell culture transfection
中文摘要
IgG的Fc部分的受体(Fc γ R)在大多数免疫球蛋白上表达。
造血细胞类型 通过结合抗原特异性免疫球蛋白,
它们提供了细胞内和细胞外
细胞之间的相互作用是必不可少的。
非适应性(先天)和适应性防御系统。 他们属于
与膜受体的异质性家族相关联,
抗体抗原复合物的细胞反应。 之多样
这些反应是结构异质性的结果,
Fc γ R,与其胞质内结构域的差异有关,
在受体复合物或受体相关的存在下,
对受体表达和信号传导都很重要的分子
转导 我们已经证明,低亲和力的受体,
自然杀伤(NK)细胞和巨噬细胞(Fc γ RIIIA)上表达的IgG
一种跨膜糖蛋白,在配体结合后调节功能
这些细胞通过转导信号导致细胞活化。
其在多形核中性粒细胞(Fc γ RIIIB)上的对应物,a
糖硅磷脂酰肌醇连接的分子,缺乏这种
功能协调发展的 通过Fc γ RIII诱导的NK细胞活化主要依赖于
对激酶的诱导激活。 这个理论的工作假设是
建议是,不同的专门效应器功能介导的
不同的Fc γ R类型,这取决于诱导不同的
在相同或不同的细胞类型的生化事件,
Fc γ R与其它蛋白质的相互作用在该功能中协同作用。
为了阐明不同类型的Fc γ R对NK细胞的作用,
细胞,骨髓单核细胞和淋巴细胞,我们建议:1)识别
这些分子在Fc γ RIII与NK细胞相互作用时被激活,
细胞与其配体,调节信号转导,和2)分析
不同Fc γ R的功能作用及其调节机制
B淋巴细胞和骨髓单核细胞上的类型。 我们特别
建议鉴定Fc γ RIII-配体激活的激酶
约束力 这些激酶的底物的作用,
磷酸酶,在控制Fc γ RIII介导的信号转导中
也将进行分析。 发生在
骨髓/单核细胞和B淋巴细胞
将研究不同Fc γ R之间的相互作用,
将对相同细胞类型进行解剖,以确定
由Fc γ RII在这些细胞上发挥作用。 这些研究预计将
导致识别的共同或独特的特点,
FcgammaR的行为,以提供关于FcgammaR依赖性
造血细胞的功能,并提出理解的基础
先天免疫系统细胞功能的机制
防御是有规律的。
英文摘要
Receptors for the Fc portion of IgG (FcgammaR) are expressed on most
hematopoietic cell types. By binding antigen specific immunoglobulins,
they provide an important link between the intra and extracellular
compartments and are essential for the interactions between cells of the
non adaptive (innate) and the adaptive systems of defense. They belong
to an heterogeneous family of membrane receptors and mediate a wide array
of cellular responses to antibody antigen complexes. The diversity of
these responses is the result of the structural heterogeneity of the
FcgammaR, related to differences in their intracytoplasmic domains, and
to the presence, within the receptor complex, or receptor associated
molecules that are important both for receptor expression and signal
transduction. We have demonstrated that the low affinity receptor for
IgG expressed on Natural Killer (NK) cells and macrophages (FcgammaRIIIA)
transmembrane glycoprotein that, upon ligand binding, regulates functions
of these cells by transducing signals that result in cell activation.
Its counterpart on polymorphonuclear neutrophils (FcgammaRIIIB), a
glycosilphosphatidylinositol linked molecule, is devoid of such
functions. NK cell activation induced via FcgammaRIII primarily depends
on induced activation of kinases. The working hypothesis of this
proposal is that distinct specialized effector functions are mediated by
different FcgammaR types, that depend on induction of distinct
biochemical events in the same or different cell types, and that
interactions of FcgammaR with other proteins cooperate in this function.
In order to elucidate the role of the different types of FcgammaR on NK
cells, myelomonocytic cells, and lymphocytes, we propose: 1) to identify
those molecules that, activated upon interaction of FcgammaRIII on NK
cells with its ligands, regulate signal transduction, and 2) to analyze
functional role, an the mechanisms regulating them, of distinct FcgammaR
types on B lymphocytes and myelomonocytic cells. Specifically, we
propose to identify the kinases activated upon FcgammaRIII-ligand
binding. The role of the substrates for these kinases, and of
phosphatases, in controlling FcGgammaRIII-mediated signal transduction
will also be analyzed. The molecular events occurring in
myeloid/monocytic cells and B lymphocytes upon immune complexes binding
will be studied and the interactions between different FcgammaR expressed
on the same cell types will be dissected, to determine the relative role
played by FcgammaRII on these cells. These studies are expected to
result in the identification of common or distinctive features of
behavior of FcgammaR, to provide information on FcgammaR-dependent
functions on hematopoietic cells, and to pose the basis for understanding
the mechanisms by which functions of cells of the innate system of
defense are regulated.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Production of granulocyte-macrophage colony-stimulating factor but not IL-3 by normal and neoplastic human B lymphocytes.
正常和肿瘤性人 B 淋巴细胞产生粒细胞-巨噬细胞集落刺激因子,但不产生 IL-3。
DOI:
--
发表时间:
1992
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Zupo,S, Perussia,B, Baldi,L, Corcione,A, Dono,M, Ferrarini,M, Pistoia,V]
通讯作者:
Pistoia,V
DOI:
10.4049/jimmunol.161.12.6648
发表时间:
1998-12
期刊:
Journal of immunology
影响因子:
4.4
作者:
[R. Trotta;Kristin A. Puorro;M. Paroli;L. Azzoni;Bekele Abebe;L. Eisenlohr;B. Perussia]
通讯作者:
R. Trotta;Kristin A. Puorro;M. Paroli;L. Azzoni;Bekele Abebe;L. Eisenlohr;B. Perussia
Ligand binding to Fc gamma R induces c-myc-dependent apoptosis in IL-2-stimulated NK cells.
配体与 Fc gamma R 结合可诱导 IL-2 刺激的 NK 细胞发生 c-myc 依赖性细胞凋亡。
DOI:
--
发表时间:
1995
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Azzoni,L, Anegon,I, Calabretta,B, Perussia,B]
通讯作者:
Perussia,B
FLOW CYTOMETRY FACILITY HIGH SPEED SORTER: LEUKEMIA
-
批准号:7166527
-
项目类别:
-
资助金额:$6.86万
-
财政年份:2005
-
负责人:BICE PERUSSIA
-
依托单位:
FLOW CYTOMETRY FACILITY HIGH SPEED SORTER
-
批准号:6877619
-
项目类别:
-
资助金额:$25.67万
-
财政年份:2005
-
负责人:BICE PERUSSIA
-
依托单位:
FLOW CYTOMETRY FACILITY HIGH SPEED SORTER: AIDS
-
批准号:7166526
-
项目类别:
-
资助金额:$3.52万
-
财政年份:2005
-
负责人:BICE PERUSSIA
-
依托单位:
FLOW CYTOMETRY FACILITY HIGH SPEED SORTER: IMMUNOLOGY
-
批准号:7166528
-
项目类别:
-
资助金额:$15.3万
-
财政年份:2005
-
负责人:BICE PERUSSIA
-
依托单位:
Activation of Innate Immunity Effector Cells
-
批准号:6768628
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2003
-
负责人:BICE PERUSSIA
-
依托单位:
Activation of Innate Immunity Effector Cells
-
批准号:6670532
-
项目类别:
-
资助金额:$17.66万
-
财政年份:2003
-
负责人:BICE PERUSSIA
-
依托单位:
Activation of Innate Immunity Effector Cells
-
批准号:6838210
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2003
-
负责人:BICE PERUSSIA
-
依托单位:
TRAINING PROGRAM IN CANCER IMMUNOLOGY
-
批准号:6783262
-
项目类别:
-
资助金额:$23.73万
-
财政年份:1993
-
负责人:BICE PERUSSIA
-
依托单位:
TRAINING PROGRAM IN CANCER IMMUNOLOGY
-
批准号:6932381
-
项目类别:
-
资助金额:$18.6万
-
财政年份:1993
-
负责人:BICE PERUSSIA
-
依托单位:
CELL SORTER FACILITY
-
批准号:3521497
-
项目类别:
-
资助金额:$26.6万
-
财政年份:1992
-
负责人:BICE PERUSSIA
-
依托单位:
ACTIVATION OF NON-MHC-RESTRICTED CYTOTOXIC LYMPHOCYTES
-
批准号:2091818
-
项目类别:
-
资助金额:$25.96万
-
财政年份:1987
-
负责人:BICE PERUSSIA
-
依托单位:
ACTIVATION OF NON MHC-RESTRICTED CYTOTOXIC LYMPHOCYTES
-
批准号:3188374
-
项目类别:
-
资助金额:$26.46万
-
财政年份:1987
-
负责人:BICE PERUSSIA
-
依托单位:
ACTIVATION OF NON MHC-RESTRICTED CYTOTOXIC LYMPHOCYTES
-
批准号:3188373
-
项目类别:
-
资助金额:$17.32万
-
财政年份:1987
-
负责人:BICE PERUSSIA
-
依托单位:
ACTIVATION OF NON MHC-RESTRICTED CYTOTOXIC LYMPHOCYTES
-
批准号:3188368
-
项目类别:
-
资助金额:$23.11万
-
财政年份:1987
-
负责人:BICE PERUSSIA
-
依托单位:
ACTIVATION OF NON MHC-RESTRICTED CYTOTOXIC LYMPHOCYTES
-
批准号:3188369
-
项目类别:
-
资助金额:$16.72万
-
财政年份:1987
-
负责人:BICE PERUSSIA
-
依托单位:
ACTIVATION OF NON MHC-RESTRICTED CYTOTOXIC LYMPHOCYTES
-
批准号:3188375
-
项目类别:
-
资助金额:$25.49万
-
财政年份:1987
-
负责人:BICE PERUSSIA
-
依托单位:
ACTIVATION OF NON-MHC-RESTRICTED CYTOTOXIC LYMPHOCYTES
-
批准号:2091820
-
项目类别:
-
资助金额:$27.46万
-
财政年份:1987
-
负责人:BICE PERUSSIA
-
依托单位:
ACTIVATION OF NON-MHC-RESTRICTED CYTOTOXIC LYMPHOCYTES
-
批准号:2414168
-
项目类别:
-
资助金额:$28.17万
-
财政年份:1987
-
负责人:BICE PERUSSIA
-
依托单位:
ACTIVATION OF NON MHC-RESTRICTED CYTOTOXIC LYMPHOCYTES
-
批准号:3188372
-
项目类别:
-
资助金额:$16.35万
-
财政年份:1987
-
负责人:BICE PERUSSIA
-
依托单位:
ACTIVATION OF NON-MHC-RESTRICTED CYTOTOXIC LYMPHOCYTES
-
批准号:2091819
-
项目类别:
-
资助金额:$26.73万
-
财政年份:1987
-
负责人:BICE PERUSSIA
-
依托单位:
海外基金